Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Mark These Tax-loss Selling Dates on Your Calendar (Updated 2024)

13 Canadian Crypto ETFs (Updated 2024)

Investing in Graphene Companies (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

10 Top Oil-producing Countries (Updated 2024)

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

A State-by-State Guide to Cannabis in Australia (Updated 2024)

When is the Starlink IPO Date and Can You Invest? (Updated 2024)

Trending Press Releases

Radiopharm achieves Nasdaq listing of ADS

US$30 Million Prepayment Term Sheet and Offtake Agreement Executed with a Global Commodities Trader

Spearmint More Than Doubles the Acreage of the George Lake South Antimony Project in New Brunswick, Canada

Mawson Finland Limited Identifies Compelling Soil Geochemical Targets for Follow-Up

COLDry Fertiliser JV Seed Funding & Working Capital Secured

Stardust Power Acquires Site, Receives Key Permit And Receives Approval For Major Construction To Commence

More Press Releases
Trending Companies

First Helium

HELI:CA

Black Swan Graphene

SWAN:CC

Purpose Bitcoin ETF

BTCC:CA

Soma Gold Corp.

SOMA:CA
More Companies
Trending Reports

2025 Gold Outlook Report

2025 Uranium Outlook

Silver Price Forecast - What Happened And Where Do We Go From Here?

2025 Crypto Outlook Report

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

BriaCell

TSX:BCT

Developing Personalized Off-The-Shelf Immunotherapy Treatments for Cancer Patients

Press Releases

BriaCell Partners with New York Cancer & Blood Specialists for Pivotal Phase 3 Study of Bria-IMT in Advanced Breast Cancer

BriaCell Initiates Pivotal Phase 3 Study of Bria-IMT in Advanced Metastatic Breast Cancer

BriaCell Reports Benchmark-Beating Patient Survival and Clinical Benefit in Advanced Metastatic Breast Cancer


Overview

BriaCell Therapeutics (NASDAQ:BCTX, BCTXW;TSX:BCT) is a clinical-phase biotechnology company developing innovative immunotherapies for treating cancer.

At the forefront of cancer treatments, immunotherapies boost the ability of the body's own cancer-fighting cells to destroy cancerous tumors. Immunotherapies also have low-toxicity, making it easier for patients to undergo treatment. Most importantly, they may offer better efficacy and less chance of recurrence for many cancer patients. A report released by Research and Markets says the global immuno-oncology market is expected to reach US$135 billion by 2024. BriaCell continues to uncover opportunities in this space with its innovative technologies.

Interactive Chart

×